These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 33158605)

  • 41. COVID-19-Induced Acute Bilateral Optic Neuritis.
    Sawalha K; Adeodokun S; Kamoga GR
    J Investig Med High Impact Case Rep; 2020; 8():2324709620976018. PubMed ID: 33238757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy.
    Merello M; Bhatia KP; Obeso JA
    Lancet Neurol; 2021 Feb; 20(2):94-95. PubMed ID: 33253627
    [No Abstract]   [Full Text] [Related]  

  • 43. In reply to: Helmich and Bloem (2020) "The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities".
    Edwards E; Carroll C
    J Parkinsons Dis; 2020; 10(3):1267-1268. PubMed ID: 32597820
    [No Abstract]   [Full Text] [Related]  

  • 44. Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Speeckaert MM; Speeckaert R; Delanghe JR
    Mov Disord; 2020 Sep; 35(9):1497. PubMed ID: 33400280
    [No Abstract]   [Full Text] [Related]  

  • 45. Viral Infection-Induced Gut Dysbiosis, Neuroinflammation, and α-Synuclein Aggregation: Updates and Perspectives on COVID-19 and Neurodegenerative Disorders.
    Follmer C
    ACS Chem Neurosci; 2020 Dec; 11(24):4012-4016. PubMed ID: 33244974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unsupervised Walking Activity Assessment Reveals COVID-19 Impact on Parkinson's Disease Patients.
    Vila-Viçosa D; Clemente A; Pona-Ferreira F; Leitão M; Bouça-Machado R; Kauppila LA; Costa RM; Matias R; Ferreira JJ
    Mov Disord; 2021 Mar; 36(3):531-532. PubMed ID: 33427331
    [No Abstract]   [Full Text] [Related]  

  • 47. Parkinson's Disease and COVID-19: Do We Need to Be More Patient?
    Gonzalez-Latapi P; Fearon C; Fasano A; Lang AE
    Mov Disord; 2021 Feb; 36(2):277. PubMed ID: 33599003
    [No Abstract]   [Full Text] [Related]  

  • 48. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.
    De Felice FG; Tovar-Moll F; Moll J; Munoz DP; Ferreira ST
    Trends Neurosci; 2020 Jun; 43(6):355-357. PubMed ID: 32359765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues.
    Ricardo Criado P; Pincelli TPH; Criado RFJ; Abdalla BMZ; Belda Junior W
    Exp Dermatol; 2020 Oct; 29(10):936-944. PubMed ID: 32867008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection.
    Maiuolo J; Mollace R; Gliozzi M; Musolino V; Carresi C; Paone S; Scicchitano M; Macrì R; Nucera S; Bosco F; Scarano F; Zito MC; Ruga S; Tavernese A; Mollace V
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seroprevalence of SARS-CoV-2 in Parkinson's Disease Patients: A Case-Control Study.
    Salari M; Etemadifar M; Zali A; Medghalchi A; Tehrani Fateh S; Aminzade Z; Bagheri Moghaddam S
    Mov Disord; 2021 Apr; 36(4):794-795. PubMed ID: 33733511
    [No Abstract]   [Full Text] [Related]  

  • 52. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.
    Calderón-Garcidueñas L; Torres-Jardón R; Franco-Lira M; Kulesza R; González-Maciel A; Reynoso-Robles R; Brito-Aguilar R; García-Arreola B; Revueltas-Ficachi P; Barrera-Velázquez JA; García-Alonso G; García-Rojas E; Mukherjee PS; Delgado-Chávez R
    J Alzheimers Dis; 2020; 78(2):479-503. PubMed ID: 32955466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
    Kabeerdoss J; Danda D
    Int J Rheum Dis; 2020 Aug; 23(8):998-1008. PubMed ID: 32779341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid worsening in Parkinson's disease may hide COVID-19 infection.
    Hainque E; Grabli D
    Parkinsonism Relat Disord; 2020 Jun; 75():126-127. PubMed ID: 32414669
    [No Abstract]   [Full Text] [Related]  

  • 55. Concerns Raised by Publication of Antonini et al., "Outcome of Parkinson Disease Patients Affected by Covid-19".
    Raphael KG
    Mov Disord; 2020 Aug; 35(8):1297. PubMed ID: 32780512
    [No Abstract]   [Full Text] [Related]  

  • 56. SARS-CoV-2 and prostatitis: Dangerous relationship for male sexual and reproductive health.
    Cardona Maya WD; Carvajal A
    Med Hypotheses; 2020 Nov; 144():109914. PubMed ID: 32505071
    [No Abstract]   [Full Text] [Related]  

  • 57. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reply to: "Concerns Raised by Publication of Antonini et al., 'Outcome of Parkinson Disease Patients Affected by Covid-19'".
    Antonini A; Leta V; Teo J; Ray Chaudhuri K
    Mov Disord; 2020 Aug; 35(8):1298. PubMed ID: 32780513
    [No Abstract]   [Full Text] [Related]  

  • 59. Reply to: Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Cereda E; Fasano A; Pezzoli G
    Mov Disord; 2020 Sep; 35(9):1498. PubMed ID: 33400277
    [No Abstract]   [Full Text] [Related]  

  • 60. Headaches During COVID-19: My Clinical Case and Review of the Literature.
    Belvis R
    Headache; 2020 Jul; 60(7):1422-1426. PubMed ID: 32413158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.